Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nano Medic Sweden AB
AB
In liquidation
Org 5591863534
Research and experimental development on biotechnology
· NACE 7211
Est. 2018
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
Nano Medic Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
Income statement
SEK thousands
Item
2019
2020
Revenue
0
0
Staff expenses
—
—
EBITDA
−109
−120
Depreciation & amort.
−0
−0
EBIT
−109
−120
Net financials
—
—
Profit before tax
−109
−120
Tax
−0
−0
Net profit
−109
−120
Balance sheet
SEK thousands
Item
2019
2020
Total assets
113
43
Equity
−59
−179
Long-term debt
0
0
Short-term debt
173
223
Total debt
173
223
Financial ratios
5-year trend
EBITDA margin
-12000000.0%
This company
15.8%
Market median
-75949467% vs market
2019
2020
Equity ratio
-416.3%
This company
38.2%
Market median
-1190% vs market
2019
2020
Return on equity
-12000000.0%
This company
18.4%
Market median
-65217491% vs market
2019
2020
Net profit margin
-12000000.0%
This company
8.1%
Market median
-148148248% vs market
2019
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2020
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
2019
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-12-31
View
PDF
More on Nano Medic Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
